Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-4 of 4
Keywords: VEGF
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Journal:
Oncology Research and Treatment
Oncol Res Treat (2018) 41 (4): 166–171.
Published Online: 23 March 2018
...Katja Zirlik; Justus Duyster Summary Angiogenesis, the process leading to the formation of new blood vessels, is one of the hallmarks of cancer. Extensive studies established that i) vascular endothelial growth factor (VEGF) is a key driver of sprouting angiogenesis, ii) VEGF is overexpressed...
Journal Articles
Subject Area:
Oncology
Jingfang Lv, Baocun Sun, Huizhi Sun, Yanhui Zhang, Junying Sun, Xiulan Zhao, Qiang Gu, Xueyi Dong, Na Che
Journal:
Oncology Research and Treatment
Oncol Res Treat (2017) 40 (1-2): 35–41.
Published Online: 25 January 2017
... MMP-2 MMP-9 VEGF VEGFR Gastric cancer (GC) is one of the most frequent gastrointestinal malignancies, accounting for 10% of all newly diagnosed cancers [ 1 ]. It is the second leading cause of death from cancer with approximately 800,000 deaths each year worldwide [ 2 ]. The overall 5-year...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology Research and Treatment
Oncol Res Treat (2014) 37 (4): 209–212.
Published Online: 20 March 2014
...: The pattern of progression upon vascular endothelial growth factor (VEGF)-targeting antiangiogenic treatment in hemangioblastoma may involve increased tumor invasiveness. 6 09 2013 9 12 2013 20 03 2014 © 2014 S. Karger GmbH, Freiburg Copyright / Drug Dosage / Disclaimer Copyright: All...
Journal Articles
Lothar Bergmann, Jochaim Beck, Kathrin Bothe, Olaf A. Brinkmann, Stephan Buse, Peter J. Goebell, Viktor Grünwald, Konstantin Holzapfel, Hubert Kübler, Norbert W. Marschner, Gerald Mickisch, Wolfgang Schultze-Seemann, Michael Siebels, Stephan Siemer, Stephan Störkel, Jürgen E. Gschwend
Journal:
Oncology Research and Treatment
Oncol Res Treat (2014) 37 (3): 136–141.
Published Online: 26 February 2014
... are available for mRCC. The mechanism of action of vascular endothelial growth factor (VEGF) and VEGF receptor or mTOR inhibition is well documented by phase III trials and reflected in the current guidelines. However, no predictive biomarkers have been identified in mRCC so far to demonstrate a benefit...
